← Back to Patent Explorer
US4912128A Expired / Lapsed US ⏱️ 0.0 years remaining

Novel pyrrolidine-2-(1,3-dicarbonyl) derivatives, a process for their preparation, agents containing them, and their use

Assignee: Hoechst AG
•
Filing: 1988-04-08
•
Granted: 1990-03-27
•
Expires: 2008-04-08
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Novel pyrrolidine-2-(1,3-dicarbonyl) derivatives, a process for their preparation, agents containing them, and their use The invention relates to pyrrolidine derivatives of the general formula ##STR1## in which R 1 , R 2 , R 3 , R 4 , R 5 and R 6 have the meaning specified in the description, X denotes oxygen, imino or alkylimino, m is 0-5, n is 0-2 and s is 0 or 1, a process for their preparation, agents containing them, and their use.

Inventors

  • 👤 Rainer Henning
  • 👤 Franz Hock
  • 👤 Hansjorg Urbach

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-01 05:49
CPC Classifications
C; C07; C07D; C07D207/00; C07D207/02; C07D207/04; C07D207/08; A; A61; A61P; A61P25/00; A61P25/18; A61P43/00; C07D207/10; C07D207/16; C07D401/00; C07D401/14

Claims Analysis

Total Claims: 20
Claim 1
Independent Claim 579 words
A compound of the formula I ##STR15## in which R 1 denotes hydrogen; (C 1 -C 6 )-alkyl; or (C 6 -C 12 )-aryl, said aryl being optionally substituted by one, two or three identical or different radicals selected from (C 1 -C 4 )-alkyl, (C 1 -C 4 )-alkoxy, halogen, nitro, hydroxyl, amino, (C 1 -C 4 )-alkylamino and di-(C 1 -C 4 )-alkylamino, or one (C 1 or C 2 )-alkylenedioxy; R 2 denotes hydrogen; (C 1 -C 6 )-alkyl; (C 6 -C 12 )-aryl; (C 6 -C 12 )-aryloxy; (C 7 -C 13 )-aroyl; hydroxyl or (C 1 -C 4 )-alkoxy, where said aryl, aryloxy and aroyl are in each case optionally substituted by one, two or three identical or different radicals selected from (C 1 -C 4 )-alkyl, (C 1 -C 4 )-alkoxy, halogen, nitro, hydroxyl, amino, (C 1 -C 4 )-alkylamino and di-(C 1 -C 4 )-alkylamino, or by one (C 1 or C 2 )-alkylenedioxy; or R 1 and R 2 together represent benzylidene in which the phenyl ring is optionally substituted by one, two or three identical or different radicals selected from (C 1 -C 4 )-alkyl, (C 1 -C 4 )-alkoxy, halogen, nitro, hydroxyl, amino, (C 1 -C 4 )-alkylamino and di-(C 1 -C 4 )-alkylamino, or by one (C 1 or C 2 )-alkylenedioxy; R 5 denotes hydrogen; (C 1 -C 6 )-alkyl; (C 6 -C 12 )-aryl-(C 1 -C 5 )-alkyl which is optionally substituted in the aryl part by one, two or three identical or different radicals selected from (C 1 -C 4 )-alkyl, (C 1 -C 4 )-alkoxy, halogen, nitro, hydroxyl, amino, (C 1 -C 4 )-alkylamino and di-(C 1 -C 4 )-alkylamino, or by one (C 1 or C 2 )-alkylenedioxy; R 6 denotes (C 1 -C 8 )-alkyl; (C 6 -C 12 )-aryl; (C 6 -C 12 )-aryl-(C 1 -C 6 )-alkyl; hydroxyl; (C 1 -C 8 )-alkoxy; (C 6 -C 12 )-aryloxy or (C 6 -C 12 )-aryl-(C 1 -C 6 )-alkoxy, where said aryl, aralkyl, aryloxy and arylalkoxy groups are in each case optionally substituted in the aryl part by one, two or three identical or different radicals selected from (C 1 -C 4 )-alkyl, (C 1 or C 2 )-alkoxy, halogen and nitro, or by one (C 1 or C 2 )-alkylenedioxy; or R 6 represents a radical of the formula --NR 7 R 8 in which R 7 and R 8 are identical or different and denote hydrogen; (C 1 -C 8 )-alkyl; (C 4 -C 10 )-cycloalkyl; (C 1 -C 4 )-alkyl-(C 4 -C 10 )-cycloalkyl; (C 6 -C 12 )-aryl; (C 6 -C 12 )-aryl-(C 1 -C 6 )-aryl; amino-(C 1 -C 8 )-alkyl; (C 1 -C 4 )-alkylamino-(C 1 -C 8 )-alkyl; di-(C 1 -C 4 )-alkylamino-(C 1 -C 8 )-alkyl; hydroxy-(C 1 -C 8 )-alkyl or (C 1 -C 4 )-alkoxy-(C 1 -C 8 )-alkyl, where said aryl and aralkyl groups are in each case optionally substituted in the aryl part by one, two or three identical or different radicals selected from (C 1 -C 4 )-alkyl, (C 1 or C 2 )-alkoxy, (C 1 -C 4 )-alkylamino, di-(C 1 -C 4 )-alkylamino, halogen, hydroxyl and amino, or by one (C 1 or C 2 )-alkylenedioxy; X denotes oxygen; imino or N-(C 1 -C 8 )-alkylimino; m is 0, 1, 2, 3, 4 or 5; and s is 0 or 1; or a physiologically acceptable salt thereof.
Claim 2
Dependent Claim 579 words
A compound of the formula I ##STR15## in which R 1 denotes hydrogen; (C 1 -C 6 )-alkyl; or (C 6 -C 12 )-aryl, said aryl being optionally substituted by one, two or three identical or different radicals selected from (C 1 -C 4 )-alkyl, (C 1 -C 4 )-alkoxy, halogen, nitro, hydroxyl, amino, (C 1 -C 4 )-alkylamino and di-(C 1 -C 4 )-alkylamino, or one (C 1 or C 2 )-alkylenedioxy; R 2 denotes hydrogen; (C 1 -C 6 )-alkyl; (C 6 -C 12 )-aryl; (C 6 -C 12 )-aryloxy; (C 7 -C 13 )-aroyl; hydroxyl or (C 1 -C 4 )-alkoxy, where said aryl, aryloxy and aroyl are in each case optionally substituted by one, two or three identical or different radicals selected from (C 1 -C 4 )-alkyl, (C 1 -C 4 )-alkoxy, halogen, nitro, hydroxyl, amino, (C 1 -C 4 )-alkylamino and di-(C 1 -C 4 )-alkylamino, or by one (C 1 or C 2 )-alkylenedioxy; or R 1 and R 2 together represent benzylidene in which the phenyl ring is optionally substituted by one, two or three identical or different radicals selected from (C 1 -C 4 )-alkyl, (C 1 -C 4 )-alkoxy, halogen, nitro, hydroxyl, amino, (C 1 -C 4 )-alkylamino and di-(C 1 -C 4 )-alkylamino, or by one (C 1 or C 2 )-alkylenedioxy; R 5 denotes hydrogen; (C 1 -C 6 )-alkyl; (C 6 -C 12 )-aryl-(C 1 -C 5 )-alkyl which is optionally substituted in the aryl part by one, two or three identical or different radicals selected from (C 1 -C 4 )-alkyl, (C 1 -C 4 )-alkoxy, halogen, nitro, hydroxyl, amino, (C 1 -C 4 )-alkylamino and di-(C 1 -C 4 )-alkylamino, or by one (C 1 or C 2 )-alkylenedioxy; R 6 denotes (C 1 -C 8 )-alkyl; (C 6 -C 12 )-aryl; (C 6 -C 12 )-aryl-(C 1 -C 6 )-alkyl; hydroxyl; (C 1 -C 8 )-alkoxy; (C 6 -C 12 )-aryloxy or (C 6 -C 12 )-aryl-(C 1 -C 6 )-alkoxy, where said aryl, aralkyl, aryloxy and arylalkoxy groups are in each case optionally substituted in the aryl part by one, two or three identical or different radicals selected from (C 1 -C 4 )-alkyl, (C 1 or C 2 )-alkoxy, halogen and nitro, or by one (C 1 or C 2 )-alkylenedioxy; or R 6 represents a radical of the formula --NR 7 R 8 in which R 7 and R 8 are identical or different and denote hydrogen; (C 1 -C 8 )-alkyl; (C 4 -C 10 )-cycloalkyl; (C 1 -C 4 )-alkyl-(C 4 -C 10 )-cycloalkyl; (C 6 -C 12 )-aryl; (C 6 -C 12 )-aryl-(C 1 -C 6 )-aryl; amino-(C 1 -C 8 )-alkyl; (C 1 -C 4 )-alkylamino-(C 1 -C 8 )-alkyl; di-(C 1 -C 4 )-alkylamino-(C 1 -C 8 )-alkyl; hydroxy-(C 1 -C 8 )-alkyl or (C 1 -C 4 )-alkoxy-(C 1 -C 8 )-alkyl, where said aryl and aralkyl groups are in each case optionally substituted in the aryl part by one, two or three identical or different radicals selected from (C 1 -C 4 )-alkyl, (C 1 or C 2 )-alkoxy, (C 1 -C 4 )-alkylamino, di-(C 1 -C 4 )-alkylamino, halogen, hydroxyl and amino, or by one (C 1 or C 2 )-alkylenedioxy; X denotes oxygen; imino or N-(C 1 -C 8 )-alkylimino; m is 0, 1, 2, 3, 4 or 5; and s is 0 or 1; or a physiologically acceptable salt thereof.
Claim 3
Dependent Claim 171 words
A compound of the formula I as claimed in claim 1, in which R 1 and R 2 are identical or different and denote hydrogen; or phenyl, said phenyl being optionally substituted by one or two identical or different radicals selected from methyl, ethyl, methoxy, fluorine, chlorine, bromine, nitro, hydroxyl, amino, methylamino and dimethylamino, or by three methoxy, or by one methylenedioxy; R 5 denotes hydrogen; R 6 represents methoxy or a radical of the formula --NR 7 R 8 in which R 7 and R 8 are identical or different and denote hydrogen; (C 1 -C 6 )-alkyl; (C 5 -C 8 )-cycloalkyl; (C 1 or C 2 )-alkyl-(C 5 -C 8 )-cycloalkyl; phenyl; phenyl-(C 1 -C 4 )-alkyl; amino-(C 1 -C 4 )-alkyl; (C 1 or C 2 )-alkylamino-(C 1 -C 4 )-alkyl; di-(C 1 or C 2 )-alkylamino-(C 1 -C 4 )-alkyl; hydroxy-(C 1 -C 4 )-alkyl or (C 1 or C 2 )-alkoxy-(C 1 -C 4 )-alkyl; and X denotes oxygen; or a physiologically acceptable salt thereof.
Claim 4
Dependent Claim 134 words
A compound of the formula I as claimed in claim 1, in which R 1 and R 2 are identical or different and denote hydrogen; phenyl; o-, m- or p-tolyl; o-, m- or p-chlorophenyl; o-, m- or p-fluorophenyl; o-, m- or p-methoxyphenyl or 2,3-, 2,4-, 2,5-, 2,6-, 3,4- or 3,5-dimethoxyphenyl; R 5 denotes hydrogen; R 6 denotes methoxy or a radical of the formula --NR 7 R 8 in which R 7 and R 8 are identical or different and denote hydrogen; (C 1 -C 6 )-alkyl; (C 5 -C 8 )-cycloalkyl; phenyl; phenyl-(C 1 -C 4 )-alkyl; amino-(C 1 -C 4 )-alkyl; methylamino-(C 1 -C 4 )-alkyl; dimethylamino-(C 1 -C 4 )-alkyl; hydroxy-(C 1 -C 4 )-alkyl or methoxy-(C 1 -C 4 )-alkyl; and X denotes oxygen; or a physiologically acceptable salt thereof.
Claim 5
Dependent Claim 36 words
A compound of the formula I as claimed in claim 1, in which R 2 denotes hydrogen; R 5 denotes hydrogen; X denotes oxygen; m is 0, 1 or 2; or a physiologically acceptable salt thereof.
Claim 6
Dependent Claim 52 words
A compound of the formula I as claimed in claim 1, in which R 5 denotes hydrogen; and R 7 and R 8 are identical or different and denote hydrogen; (C 1 -C 6 )-alkyl; phenyl-(C 1 -C 4 )-alkyl; or dimethylamino-(C 1 -C 4 )-alkyl; or a pharmaceutically acceptable salt thereof.
Claim 7
Dependent Claim 77 words
A compound of the formula I as claimed in claim 1, in which R 1 and R 2 are identical or different and denote hydrogen, phenyl or p-methoxyphenyl; R 5 denotes hydrogen; R 6 denotes methoxy or a radical of the formula --NR 7 R 8 in which R 7 denotes hydrogen and R 8 denotes phenylmethyl, phenylethyl, phenylpropyl, dimethylaminopropyl or (1-methyl,1-phenyl)methyl; X denotes oxygen; m is 0, 1 or 2; or a physiologically acceptable salt thereof.
Claim 8
Dependent Claim 99 words
A compound of the formula I as claimed in claim 1 in which R 1 and R 2 are identical or different and denote hydrogen; (C 1 -C 6 )-alkyl; or (C 6 -C 12 )-aryl, said aryl being optionally substituted by one, two or three identical or different radicals selected from (C 1 -C 4 )-alkyl, (C 1 -C 4 )-alkoxy, halogen, nitro, hydroxyl, amino, (C 1 -C 4 )-alkylamino and di-(C 1 -C 4 )-alkylamino, or one (C 1 or C 2 )-alkylenedioxy; R 5 denotes hydrogen; and X denotes oxygen; or a physiologically acceptable salt thereof.
Claim 9
Dependent Claim 8 words
The compound of claim 1 which is N-benzyl-3-[N-(N-benzyloxycarbonyl-S-prolyl)-pyrrolidin-2-S-yl]-3-oxo-2,2-difluoropropionamide.
Claim 10
Dependent Claim 8 words
The compound of claim 1 which is N-benzyl-3-[N-[N-(4-phenylbutyryl)-S-prolyl]-pyrrolidin-2-S-yl]-3-oxo-2,2-difluoropropionamide.
Claim 11
Dependent Claim 8 words
The compound of claim 1 which is N-(2-phenylethyl)-3-[N-(N-benzyloxycarbonyl-S-prolyl)-pyrrolidin-2-S-yl]-3-oxo-2,2-difluoropropionamide.
Claim 12
Dependent Claim 8 words
The compound of claim 1 which is N-(3-phenylpropyl)-3-[N-(N-benzyloxycarbonyl-S-prolyl)-pyrrolidin-2-S-yl]-3-oxo-2,2-difluoropropionamide.
Claim 13
Dependent Claim 8 words
The compound of claim 1 which is N-(1-S-phenylethyl)-3-[N-(N-benzyloxycarbonyl-S-prolyl)-pyrrolidin-2-S-yl]-3-oxo-2,2-difluoropropionamide.
Claim 14
Dependent Claim 8 words
The compound of claim 1 which is N-(1-R-phenylethyl)-3-[N-(N-benzyloxycarbonyl-S-prolyl)-pyrrolidin-2-S-yl]-3-oxo-2,2-difluoropropionamide.
Claim 15
Dependent Claim 8 words
The compound of claim 1 which is N-(2-phenylethyl)-3-[N-(N-benzhydrylmethylcarbonyl-S-prolyl)-pyrrolidin-2-S-yl]-3-oxo-2,2-difluoropropionamide.
Claim 16
Dependent Claim 8 words
The compound of claim 1 which is N-benzyl-3-[N-(N-benzhydrylmethylcarbonyl-S-prolyl)-pyrrolidin-2-S-yl]-3-oxo-2,2-difluoropropionamide.
Claim 17
Dependent Claim 8 words
The compound of claim 1 which is N-(1-R-phenylethyl)-3-[N-(N-benzhydrylmethylcarbonyl-S-prolyl)-pyrrolidin-2-S-yl]-3-oxo-2,2-difluoropropionamide.
Claim 18
Dependent Claim 41 words
A pharmaceutical composition comprising a compound of the formula I or a pharmaceutically acceptable salt thereof as claimed in claim 1 in an amount effective for treating at least one disease of the central nervous system, and a pharmaceutically acceptable carrier.
Claim 19
Dependent Claim 52 words
A pharmaceutical composition comprising a compound of the formula I or a pharmaceutically acceptable salt thereof as claimed in claim 1 in an amount effective for treating at least one disease of the central nervous system, wherein said compound or said salt is an inhibitor of prolylendopeptidase, and a pharmaceutically acceptable carrier.
Claim 20
Dependent Claim 38 words
A method of inhibiting prolyl-endopeptidase by administering a compound of formula I or a pharmaceutically acceptable salt thereof as claimed in claim 1 in an amount effective for treating at least one disease of the central nervous system.

References Cited (Backward Citations)

US4077951A Cited
US4560795A Cited
US4499102A Cited
US4277395A Cited
US4439619A Cited
US4456594A Cited
US4483991A Cited
US4518528A Cited
US4719200A Cited
US4762821A Cited
US4720554A Cited
EP0268281A2 Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1993-03-26 1993-09-25 1994-03-27 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1997-03-26 1997-09-25 1998-03-27 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2001-03-26 2001-09-25 2002-03-27 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag